Artificial Intelligence in Breast Imaging and Screening: Current Evidence, Applications, and Future Directions
Open Access
- 13 August 2026
- journal article
- review article
- Published by Georg Thieme Verlag KG in Indian Journal of Radiology and Imaging
- Vol. 36 (04) , 590-600
Abstract
Artificial intelligence (AI) has emerged as a clinically significant and rapidly evolving technology in breast imaging, with applications spanning cancer detection, risk prediction, workflow optimization, and supplemental imaging modalities. The evidence base has matured rapidly, transitioning from retrospective accuracy studies to prospective randomized controlled trials. This narrative review synthesizes the most recent evidence (2023–2026) on AI applications in breast cancer screening and imaging, including landmark trial results, systematic reviews, and society recommendations. Current data demonstrate that AI-supported mammography screening can increase cancer detection rates by 10 to 29% and reduce interval cancer rates by up to 12% while reducing radiologist workload by 31 to 64% in double-reading screening settings, without increasing false-positive rates. However, the evidence base remains predominantly derived from nondiverse, high-income country populations, and long-term outcome data including breast cancer mortality are not yet available. Challenges related to generalizability, algorithmic bias, overdiagnosis, and regulatory frameworks remain. As the field moves toward clinical implementation, rigorous post-market surveillance, diverse dataset validation, and cost-effectiveness analyses will be essential.Keywords
This publication has 29 references indexed in Scilit:
- AI software as a third reader in breast cancer screening—a prospective diagnostic observational studyEuropean Radiology, 2026
- Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trialThe Lancet, 2026
- ESR Essentials: artificial intelligence in breast imaging—practice recommendations by the European Society of Breast ImagingEuropean Radiology, 2025
- Global disparities in artificial intelligence-based mammogram interpretation for breast cancer: A scientometric analysis of representation, trends, and equityEuropean Journal of Cancer, 2025
- Artificial Intelligence for breast cancer detection: Technology, challenges, and prospectsEuropean Journal of Radiology, 2024
- AI Applications to Breast MRI: Today and TomorrowJournal of Magnetic Resonance Imaging, 2024
- Artificial Intelligence-Driven Mammography-Based Future Breast Cancer Risk Prediction: A Systematic ReviewJournal of the American College of Radiology, 2023
- Barriers and facilitators of artificial intelligence conception and implementation for breast imaging diagnosis in clinical practice: a scoping reviewEuropean Radiology, 2023
- Artificial intelligence-supported screen reading versus standard double reading in the Mammography Screening with Artificial Intelligence trial (MASAI): a clinical safety analysis of a randomised, controlled, non-inferiority, single-blinded, screening accuracy studyThe Lancet Oncology, 2023
- External Validation of an Ensemble Model for Automated Mammography Interpretation by Artificial IntelligenceJAMA Network Open, 2022